Drug intelligence / Profile preview

gallium Ga 68-edotreotide

Development stage
Approved
Lead developer
University of Iowa
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

Gallium Ga 68-edotreotide is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for the localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. It consists of an 8 amino acid peptide (edotreotide, also known as DOTATOC) bound to the chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and labeled with the radioactive isotope gallium-68. The compound binds to somatostatin receptors, with higher affinity for somatostatin receptor type 2, where it emits beta particle radiation for detection by PET.

Brand names
Somakit TOC
Other names
Gallium Ga 68-dotatocGallium (68Ga) edotreotideGallium edotreotide Ga-68Gallium-68 (DOTA0-Phel-Tyr3)octreotideEdotreotide gallium Ga-68
02

Targets

SSTR5 (Somatostatin receptor 5)SSTR2 (Somatostatin receptor type 2)

Beyond the preview

Go deeper on gallium Ga 68-edotreotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium Ga 68-edotreotide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call